In the context of globalization, Cooper Pharma focuses part of its strategy on the international market, thus considering export as a vector of development and competitiveness.
Cooper Pharma has adapted its internal organization in order to create and maintain a synergy between its In-licensing and Out-licensing activities. Cooper Pharma, with its regional experience, can make its partners benefit from a broad manufacturing and marketing network deeply rooted in several countries in East Africa, West Africa, Maghreb and in Czech Republic.
In 2013, Cooper Pharma opened a subsidiary called “COOPER INTERNATIONAL”, based in Dubai, in the United Arab Emirates. This new subsidiary supports all exports activities of Cooper Pharma in Saudi Arabia, Middle East and Francophone Africa.